CASP3 and ovarian carcinoma: In this study, we further confirmed the tumor suppression efficacy of FWGE in human ovarian carcinoma cells, SKOV-3 and ES-2, by identifying the disruption of mitochondrial function and the activation of caspase-3 and -7 as well as PARP.